We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article we will summarize the bulls’ thesis on AMGN. AMGN Technologies, Inc. share was trading at $335.26 as of Sept 16th.
A pharmacy shelves stocked with pharmaceutical drugs awaiting distribution.
Amgen, a rare biotech company in the Dow index, is well-known for its flagship drug EPO, but its growth today stems from a diversified portfolio across general medicine,...
